>Европейский рынок автоматизированных клеточных культур, по продуктам (расходные материалы, инструменты), типу (бесконечные культуры клеточных линий, конечные культуры клеточных линий), применению (разработка лекарств, исследования стволовых клеток, регенеративная медицина , исследования рака, вакцины и т. д.), конечным пользователям (биотехнологические компании, исследовательские организации, академические научно-исследовательские институты и т. д.). Тенденции отрасли и прогноз до 2029 г.
Анализ и понимание рынка автоматизированных клеточных культур в Европе
Отчет о рынке автоматизированных клеточных культур содержит подробную информацию о доле рынка, новых разработках и анализе продуктового портфеля, влиянии внутренних и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и рыночный сценарий, свяжитесь с нами для получения аналитического брифинга, наша команда поможет вам создать решение по влиянию на доход для достижения желаемой цели.
Ожидается, что рынок автоматизированных клеточных культур в Европе будет расти в прогнозируемый период с 2022 по 2029 год. По данным Data Bridge Market Research, среднегодовой темп роста рынка составит 8,2% в прогнозируемый период с 2022 по 2029 год, и ожидается, что к 2029 году он достигнет 5 807,17 млн евро. Растущий спрос на технологию клеточного культивирования при производстве вакцин и широкое распространение методов клеточного культивирования в различных областях применения являются основными факторами, обусловившими рост спроса на рынке в прогнозируемый период.
|
Отчет Метрика |
Подробности |
|
Прогнозируемый период |
2022-2029 |
|
Базовый год |
2021 |
|
Исторические годы |
2020 (Можно настроить на 2019 - 2014) |
|
Количественные единицы |
Доход в млн. евро, объемы в единицах, цены в евро |
|
Охваченные сегменты |
По продукту (расходные материалы, инструменты), типу (бесконечные культуры клеточных линий, конечные культуры клеточных линий), применению (разработка лекарств, исследования стволовых клеток, регенеративная медицина , исследования рака, вакцины , другие), конечному пользователю (биотехнологические компании, исследовательские организации, академические научно-исследовательские институты, другие) |
|
Страны, охваченные |
Германия, Великобритания, Франция, Россия, Италия, Турция, Нидерланды, Швейцария, Испания, Бельгия и остальная Европа |
|
Охваченные участники рынка |
Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG и другие |
Определение рынка автоматизированных клеточных культур в Европе
Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.
Europe Automated Cell Cultures Market Dynamics
This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:
- Drivers
Increasing Demand for Cell Culture Technology in Vaccine Production
Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.
An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition, cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.
Technological Advancements in Cell Culture Technology Systems
As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.
Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the Europe automated cell cultures market growth.
- Restraint
High Cost of Automated Cell Culture Systems
The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.
The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the Europe automated cell cultures market in the forecasted period.
- Opportunity
New Product Launches and Technology Developments
Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, software’s has led to an advancement in the automated cell culture market and its growth.
The new products and technologies launched and worked upon create good opportunities for the Europe automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.
- Challenge
Development and Maintenance of Expertise
Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.
Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the Europe automated cell cultures market growth in the forecasted period.
Recent Developments
- In July 2021, the life science group Sartorius, Sartorius Stadium Biotech subgroup, acquired a majority stake in the reagent manufacturer CellGenix GmbH.
- In December 2O2O, Eppendorf presented the new modular bioreactor control system SciVario twin to its bioprocess customers in 2020. Designed to provide more flexibility in the laboratory, it allows users to control two glass bioreactors in the volume range of 0.2 to 40 liters individually or in parallel from a computer or tablet using Eppendorf’s software VisioNize – without the need to change the configuration of the hardware.
Europe Automated Cell Cultures Market Scope
Europe automated cell cultures market is segmented into Product, Type, Application, and End User. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Europe Automated Cell Cultures Market, By Product
- Consumables
- Instruments
On the basis of product, the Europe automated cell cultures market is segmented into consumables and instruments
Europe Automated Cell Cultures Market, By Type
- Infinite Cell Line Cultures
- Finite Cell Line Cultures
On the basis of type, the Europe automated cell cultures market is segmented into infinine Cell line cultures and finite Cell line cultures
Europe Automated Cell Cultures Market, By Application
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
- Vaccines
- Other
On the basis of application, the Europe automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccine and other.
Europe Automated Cell Cultures Market, By End User
- Biotech Companies
- Research Organizations
- Academic Research Institutes
- Other
On the basis of end user, the Europe automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes and other.
Europe Automated Cell Cultures Market Regional Analysis/Insights
The Europe automated cell cultures market is analyzed and market size information is provided by Product, Type, Application, and End User.
The countries covered in this market report are Germany, U.K., France, Russia, Italy, Turkey, Netherlands, Switzerland, Spain, Belgium and rest of Europe.
- In 2022, Europe automated cell cultures market is expected to grow due to increasing applications in stem cell research, vaccine production, regenerative medicines production, and drug discovery.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Automated Cell Cultures Market Share Analysis
Europe automated cell cultures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Europe automated cell cultures market.
Ключевыми игроками на европейском рынке автоматизированных клеточных культур являются Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments, Benchmark scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva (дочерняя компания Danahar Corporation), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, Ltd., HiMedia Laboratories, NanoEntek America, Inc., Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG, Thrive Bioscience, Inc. и другие.
-
Методология исследования: Европейский рынок автоматизированных клеточных культур
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Рыночные данные анализируются и оцениваются с использованием рыночных статистических и когерентных моделей. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в рыночном отчете. Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Помимо этого, модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, анализ доли рынка компании, стандарты измерения, Европа против региона и анализ доли поставщиков. Пожалуйста, запросите звонок аналитика в случае дальнейшего запроса.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORK FOR EUROPE AUTOMATED CELL CULTURES MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS
6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS
6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS
6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES
6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT
6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS
6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS
6.3.3 INCREASING OUTSOURCING FACILITIES
6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE
6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES
7 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 CONSUMABLES
7.2.1 MEDIA
7.2.1.1 SERUM FREE MEDIA
7.2.1.2 CLASSICAL MEDIA & SALTS
7.2.1.3 STEM CELL CULTURE MEDIA
7.2.1.4 SPECIALTY MEDIA
7.2.2 BUFFERS AND SUPPLEMENTS
7.2.2.1 PLASMA
7.2.2.2 SERA
7.2.2.3 FETAL BOVINE SERA
7.2.2.4 ADULT BOVINE SERA
7.2.2.5 OTHERS ANIMAL SERA
7.2.3 REAGENTS
7.2.3.1 SUPPLEMENTS & GROWTH FACTORS
7.2.3.2 BUFFERS & CHEMICALS
7.2.3.3 CELL DISASSOCIATION REAGENTS
7.2.3.4 BALANCED SALT SOLUTIONS
7.2.3.5 ATTACHMENT & MATRIX FACTORS
7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS
7.2.3.7 CONTAMINATION DETECTION KITS
7.2.3.8 CRYOPROTECTIVE REAGENTS
7.2.3.9 OTHERS CELL CULTURE REAGENTS
7.2.4 ACCESSORIES
7.3 INSTRUMENTS
7.3.1 SUPPORTING EQUIPMENTS
7.3.1.1 CELL COUNTERS
7.3.1.2 IMAGE BASED CELL COUNTERS
7.3.1.3 FLOW CYTOMETERS
7.3.1.4 COULTER COUNTERS
7.3.1.5 CELL EXPANSION
7.3.1.6 LIQUID HANDLERS
7.3.1.7 OTHERS
7.3.2 BIOREACTORS
7.3.2.1 SINGLE USE BIOREACTORS
7.3.2.2 CONVENTIONAL BIOREACTORS
7.3.2.3 OTHERS
7.3.3 STORAGE EQUIPMENTS
7.3.3.1 REFRIGERATORS & FREEZERS
7.3.3.2 CRYOSTORAGE SYSTEMS
7.3.3.3 OTHERS
8 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE
8.1 OVERVIEW
8.2 INFINITE CELL LINE CULTURES
8.3 FINITE CELL LINE CULTURES
9 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DEVELOPMENT
9.3 STEM CELL RESEARCH
9.3.1 EMBRYONIC STEM CELLS
9.3.2 TISSUE-SPECIFIC STEM CELLS
9.3.3 MESENCHYMAL STEM CELLS
9.3.4 INDUCED PLURIPOTENT STEM CELLS
9.4 REGENERATIVE MEDICINE
9.4.1 STEM CELL THERAPY
9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)
9.4.3 TISSUE ENGINEERING
9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS
9.5 CANCER RESEARCH
9.6 VACCINES
9.7 OTHERS
10 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER
10.1 OVERVIEW
10.2 BIOTECH COMPANIES
10.3 RESEARCH ORGANIZATIONS
10.4 ACADEMIC RESEARCH INSTITUTES
10.5 OTHERS
11 EUROPE AUTOMATED CELL CULTURES MARKET, BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 U.K.
11.1.3 FRANCE
11.1.4 RUSSIA
11.1.5 ITALY
11.1.6 TURKEY
11.1.7 NETHERLANDS
11.1.8 SWITZERLAND
11.1.9 SPAIN
11.1.10 BELGIUM
11.1.11 REST OF EUROPE
12 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 COMPANY PROFILE
13.1 LONZA
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.1.6 SWOT ANALYSIS
13.2 MERCK KGAA
13.2.1 COMPANY SNAPSHOT
13.2.2 RECENT FINANCIALS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.2.6 SWOT ANALYSIS
13.3 THERMO FISHER SCIENTIFIC INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 RECENT FINANCIALS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.3.6 SWOT ANALYSIS
13.4 BD
13.4.1 COMPANY SNAPSHOT
13.4.2 RECENT FINANCIALS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.4.6 SWOT ANALYSIS
13.5 EPPENDORF AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.5.6 SWOT ANALYSIS
13.6 ADVANCED INSTRUMENTS
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 BENCHMARK SCIENTIFIC INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 BIOSPHERIX LTD.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENTS
13.9 BIOTRON HEALTHCARE
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 BULLDOG-BIO, INC.
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.11 CELL CULTURE COMPANY, LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
13.12 CELLGENIX GMBH
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 CHEMOMETEC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 CORNING INCORPORATED
13.14.1 COMPANY SNAPSHOT
13.14.2 RECENT FINANCIALS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 FUJIFILM HOLDINGS AMERICA CORPORATION
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 HAMILTON COMPANY
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENTS
13.18 HITACHI, LTD.
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 KAWASAKI HEAVY INDUSTRIES, LTD.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.2 HIMEDIA LABORATORIES
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
13.22 NEXCELOM BIOSCIENCE LLC.
13.22.1 COMPANY SNAPSHOT
13.22.2 PRODUCT PORTFOLIO
13.22.3 RECENT DEVELOPMENTS
13.23 PROMOCELL GMBH
13.23.1 COMPANY SNAPSHOT
13.23.2 PRODUCT PORTFOLIO
13.23.3 RECENT DEVELOPMENTS
13.24 RWD LIFE SCIENCE CO LTD.
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENTS
13.25 SARTORIUS AG
13.25.1 COMPANY SNAPSHOT
13.25.2 REVENUE ANALYSIS
13.25.3 PRODUCT PORTFOLIO
13.25.4 RECENT DEVELOPMENTS
13.26 SCIENTICA INSTRUMENTATION, INC.
13.26.1 COMPANY SNAPSHOT
13.26.2 PRODUCT PORTFOLIO
13.26.3 RECENT DEVELOPMENTS
13.27 SHIBUYA CORPORATION
13.27.1 COMPANY SNAPSHOT
13.27.2 RECENT FINANCIALS
13.27.3 PRODUCT PORTFOLIO
13.27.4 RECENT DEVELOPMENTS
13.28 SPHERE FLUIDICS LIMITED
13.28.1 COMPANY SNAPSHOT
13.28.2 PRODUCT PORTFOLIO
13.28.3 RECENT DEVELOPMENTS
13.29 TECAN TRADING AG
13.29.1 COMPANY SNAPSHOT
13.29.2 RECENT FINANCIALS
13.29.3 PRODUCT PORTFOLIO
13.29.4 RECENT DEVELOPMENT
13.3 THRIVE BIOSCIENCE, INC.
13.30.1 COMPANY SNAPSHOT
13.30.2 PRODUCT PORTFOLIO
13.30.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
Список таблиц
TABLE 1 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 2 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 3 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 4 EUROPE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 5 EUROPE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 6 EUROPE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)
TABLE 7 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 8 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 9 EUROPE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 10 EUROPE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 11 EUROPE STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 12 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 13 EUROPE INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 14 EUROPE FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 15 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 16 EUROPE DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 17 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 18 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 19 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 20 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 21 EUROPE CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 22 EUROPE VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 23 EUROPE OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 24 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 25 EUROPE BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 26 EUROPE RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 27 EUROPE ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 28 EUROPE OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 29 EUROPE AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)
TABLE 30 EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 31 EUROPE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 32 EUROPE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 33 EUROPE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 34 EUROPE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 35 EUROPE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 36 EUROPE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 37 EUROPE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 38 EUROPE STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 39 EUROPE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 40 EUROPE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 41 EUROPE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 42 EUROPE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 43 EUROPE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 44 GERMANY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 45 GERMANY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 46 GERMANY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 47 GERMANY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 48 GERMANY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 49 GERMANY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 50 GERMANY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 51 GERMANY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 52 GERMANY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 53 GERMANY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 54 GERMANY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 55 GERMANY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 56 GERMANY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 57 GERMANY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 58 U.K. AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 59 U.K. CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 60 U.K. MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 61 U.K. BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 62 U.K. REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 63 U.K. INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 64 U.K. SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 65 U.K. BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 66 U.K. STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 67 U.K. AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 68 U.K. AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 69 U.K. STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 70 U.K. REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 71 U.K. AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 72 FRANCE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 73 FRANCE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 74 FRANCE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 75 FRANCE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 76 FRANCE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 77 FRANCE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 78 FRANCE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 79 FRANCE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 80 FRANCE STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 81 FRANCE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 82 FRANCE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 83 FRANCE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 84 FRANCE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 85 FRANCE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 86 RUSSIA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 87 RUSSIA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 88 RUSSIA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 89 RUSSIA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 90 RUSSIA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 91 RUSSIA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 92 RUSSIA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 93 RUSSIA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 94 RUSSIA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 95 RUSSIA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 96 RUSSIA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 97 RUSSIA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 98 RUSSIA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 99 RUSSIA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 100 ITALY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 101 ITALY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 102 ITALY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 103 ITALY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 104 ITALY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 105 ITALY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 106 ITALY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 107 ITALY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 108 ITALY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 109 ITALY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 110 ITALY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 111 ITALY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 112 ITALY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 113 ITALY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 114 TURKEY AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 115 TURKEY CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 116 TURKEY MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 117 TURKEY BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 118 TURKEY REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 119 TURKEY INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 120 TURKEY SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 121 TURKEY BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 122 TURKEY STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 123 TURKEY AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 124 TURKEY AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 125 TURKEY STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 126 TURKEY REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 127 TURKEY AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 128 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 129 NETHERLANDS CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 130 NETHERLANDS MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 131 NETHERLANDS BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 132 NETHERLANDS REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 133 NETHERLANDS INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 134 NETHERLANDS SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 135 NETHERLANDS BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 136 NETHERLANDS STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 137 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 138 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 139 NETHERLANDS STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 140 NETHERLANDS REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 141 NETHERLANDS AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 142 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 143 SWITZERLAND CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 144 SWITZERLAND MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 145 SWITZERLAND BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 146 SWITZERLAND REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 147 SWITZERLAND INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 148 SWITZERLAND SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 149 SWITZERLAND BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 150 SWITZERLAND STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 151 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 152 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 153 SWITZERLAND STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 154 SWITZERLAND REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 155 SWITZERLAND AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 156 SPAIN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 157 SPAIN CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 158 SPAIN MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 159 SPAIN BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 160 SPAIN REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 161 SPAIN INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 162 SPAIN SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 163 SPAIN BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 164 SPAIN STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 165 SPAIN AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 166 SPAIN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 167 SPAIN STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 168 SPAIN REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 169 SPAIN AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 170 BELGIUM AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 171 BELGIUM CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 172 BELGIUM MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 173 BELGIUM BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 174 BELGIUM REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 175 BELGIUM INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 176 BELGIUM SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 177 BELGIUM BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 178 BELGIUM STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 179 BELGIUM AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 180 BELGIUM AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 181 BELGIUM STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 182 BELGIUM REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 183 BELGIUM AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 184 REST OF EUROPE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
Список рисунков
FIGURE 1 EUROPE AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 2 EUROPE AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE AUTOMATED CELL CULTURES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE EUROPE AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD
FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE AUTOMATED CELL CULTURES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE AUTOMATED CELL CULTURES MARKET
FIGURE 14 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021
FIGURE 15 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)
FIGURE 16 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 EUROPE AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021
FIGURE 19 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)
FIGURE 20 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 21 EUROPE AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021
FIGURE 23 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)
FIGURE 24 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 25 EUROPE AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, 2021
FIGURE 27 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)
FIGURE 28 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 EUROPE AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)
FIGURE 31 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)
FIGURE 32 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 EUROPE AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 EUROPE AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)
FIGURE 35 EUROPE AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
